rs79008328

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001105206.3(LAMA4):​c.423-4T>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0112 in 1,612,792 control chromosomes in the GnomAD database, including 188 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.018 ( 43 hom., cov: 33)
Exomes 𝑓: 0.010 ( 145 hom. )

Consequence

LAMA4
NM_001105206.3 splice_region, intron

Scores

2
Splicing: ADA: 0.0005193
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.630
Variant links:
Genes affected
LAMA4 (HGNC:6484): (laminin subunit alpha 4) Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the alpha chain isoform laminin, alpha 4. The domain structure of alpha 4 is similar to that of alpha 3, both of which resemble truncated versions of alpha 1 and alpha 2, in that approximately 1,200 residues at the N-terminus (domains IV, V and VI) have been lost. Laminin, alpha 4 contains the C-terminal G domain which distinguishes all alpha chains from the beta and gamma chains. The RNA analysis from adult and fetal tissues revealed developmental regulation of expression, however, the exact function of laminin, alpha 4 is not known. Tissue-specific utilization of alternative polyA-signal has been described in literature. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 6-112201692-A-C is Benign according to our data. Variant chr6-112201692-A-C is described in ClinVar as [Benign]. Clinvar id is 44385.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-112201692-A-C is described in Lovd as [Benign].
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0633 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LAMA4NM_001105206.3 linkc.423-4T>G splice_region_variant, intron_variant Intron 4 of 38 ENST00000230538.12 NP_001098676.2 Q16363A0A0A0MQS9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LAMA4ENST00000230538.12 linkc.423-4T>G splice_region_variant, intron_variant Intron 4 of 38 1 NM_001105206.3 ENSP00000230538.7 A0A0A0MQS9

Frequencies

GnomAD3 genomes
AF:
0.0184
AC:
2797
AN:
152228
Hom.:
44
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0382
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0172
Gnomad ASJ
AF:
0.0245
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.00819
Gnomad MID
AF:
0.0633
Gnomad NFE
AF:
0.0103
Gnomad OTH
AF:
0.0229
GnomAD3 exomes
AF:
0.0122
AC:
3054
AN:
250746
Hom.:
34
AF XY:
0.0120
AC XY:
1629
AN XY:
135496
show subpopulations
Gnomad AFR exome
AF:
0.0422
Gnomad AMR exome
AF:
0.0107
Gnomad ASJ exome
AF:
0.0242
Gnomad EAS exome
AF:
0.000163
Gnomad SAS exome
AF:
0.00346
Gnomad FIN exome
AF:
0.00695
Gnomad NFE exome
AF:
0.0124
Gnomad OTH exome
AF:
0.0160
GnomAD4 exome
AF:
0.0105
AC:
15265
AN:
1460446
Hom.:
145
Cov.:
31
AF XY:
0.0103
AC XY:
7512
AN XY:
726640
show subpopulations
Gnomad4 AFR exome
AF:
0.0425
Gnomad4 AMR exome
AF:
0.0115
Gnomad4 ASJ exome
AF:
0.0248
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00324
Gnomad4 FIN exome
AF:
0.00707
Gnomad4 NFE exome
AF:
0.00968
Gnomad4 OTH exome
AF:
0.0144
GnomAD4 genome
AF:
0.0184
AC:
2801
AN:
152346
Hom.:
43
Cov.:
33
AF XY:
0.0185
AC XY:
1376
AN XY:
74494
show subpopulations
Gnomad4 AFR
AF:
0.0383
Gnomad4 AMR
AF:
0.0171
Gnomad4 ASJ
AF:
0.0245
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00207
Gnomad4 FIN
AF:
0.00819
Gnomad4 NFE
AF:
0.0103
Gnomad4 OTH
AF:
0.0227
Alfa
AF:
0.0159
Hom.:
21
Bravo
AF:
0.0207
Asia WGS
AF:
0.00693
AC:
24
AN:
3478
EpiCase
AF:
0.0124
EpiControl
AF:
0.0148

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Dec 01, 2011
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jul 29, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Mar 05, 2014
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Dilated cardiomyopathy 1JJ Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
8.4
DANN
Benign
0.75

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00052
dbscSNV1_RF
Benign
0.044
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs79008328; hg19: chr6-112522893; API